 |
 |

Caffeine Consumption and the Risk of Breast Cancer in a Large Prospective Cohort of Women
Ken Ishitani, MD, PhD;
Jennifer Lin, PhD;
JoAnn E. Manson, MD, DrPH;
Julie E. Buring, ScD;
Shumin M. Zhang, MD, ScD
Arch Intern Med. 2008;168(18):2022-2031.
Background Prospective data relating caffeine consumption to breast cancer risk are limited.
Methods We evaluated the association between caffeine consumption and breast cancer risk in women enrolled in a completed cancer prevention trial. Detailed dietary information was obtained at baseline (1992-1995) from 38 432 women 45 years or older and free of cancer. During a mean follow-up of 10 years, we identified 1188 invasive breast cancer cases.
Results Consumption of caffeine and caffeinated beverages and foods was not statistically significantly associated with overall risk of breast cancer. The multivariate relative risks (RRs) of breast cancer were 1.02 (95% confidence interval [CI], 0.84-1.22) for caffeine (top vs bottom quintile), 1.08 (0.89-1.30) for coffee ( 4 cups daily vs almost never), and 1.03 (0.85-1.25) for tea ( 2 cups daily vs almost never). However, in women with benign breast disease, a borderline significant positive association with breast cancer risk was observed for the highest quintile of caffeine consumption (RR, 1.32; 95% CI, 0.99-1.76) and for the highest category of coffee consumption ( 4 cups daily) (1.35; 1.01-1.80); tests for interaction were marginally significant. Caffeine consumption was also significantly positively associated with risk of estrogen receptor–negative and progesterone receptor–negative breast cancer (RR, 1.68; 95% CI, 1.01-2.81) and breast tumors larger than 2 cm (1.79; 1.18-2.72).
Conclusions These data show no overall association between caffeine consumption and breast cancer risk. The possibility of increased risk in women with benign breast disease or for tumors that are estrogen and progesterone receptor negative or larger than 2 cm warrants further study.
Author Affiliations: Division of Preventive Medicine (Drs Ishitani, Lin, Manson, Buring, and Zhang) and Channing Laboratory (Dr Manson), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Department of Obstetrics and Gynecology, Tokyo Women's Medical University, Tokyo, Japan (Dr Ishitani); Department of Epidemiology, Harvard School of Public Health, Boston (Drs Manson and Buring); and Department of Ambulatory Care and Prevention, Harvard Medical School, Boston (Dr Buring).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Does Caffeine Consumption Affect Breast Cancer Risk?
JWatch Women's Health 2008;2008:2-2.
FULL TEXT
|